We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$486B
AUM Growth
+$2.12B
Cap. Flow
+$867M
Cap. Flow %
0.18%
Top 10 Hldgs %
13.96%
Holding
2,615
New
76
Increased
1,051
Reduced
777
Closed
79

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.76B
2
CI icon
Cigna
CI
+$1.44B
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.26B
4
OXY icon
Occidental Petroleum
OXY
+$763M
5
DHR icon
Danaher
DHR
+$762M

Sector Composition

Rank Sector Weight
1 Healthcare 22.87%
2 Financials 13.64%
3 Consumer Discretionary 13.54%
4 Industrials 10.67%
5 Technology 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UMH
2176
UMH Properties
UMH
$1.42B
$301K ﹤0.01%
30,700
RENT
2177
DELISTED
RENTRAK CORP
RENT
$300K ﹤0.01%
4,300
-50,000
-92% -$3.02M
MRH
2178
DELISTED
MONTPELIER RE HOLDINGS LTD
MRH
$300K ﹤0.01%
7,600
ARR
2179
Armour Residential REIT
ARR
$2.37B
$299K ﹤0.01%
2,663
PBY
2180
DELISTED
PEP BOYS MANNY MOE& JACK
PBY
$299K ﹤0.01%
24,370
ECOM
2181
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$298K ﹤0.01%
24,964
ESRT icon
2182
Empire State Realty Trust
ESRT
$836M
$297K ﹤0.01%
17,400
KERX
2183
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$297K ﹤0.01%
29,800
+6,100
+26% +$65.4K
AHT
2184
Ashford Hospitality Trust
AHT
$20.2M
$296K ﹤0.01%
35
TPC
2185
Tutor Perini Cor
TPC
$4.98B
$296K ﹤0.01%
13,700
PGNX
2186
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$294K ﹤0.01%
39,400
EPIQ
2187
DELISTED
EPIQ SYSTEMS INC
EPIQ
$294K ﹤0.01%
17,400
S
2188
DELISTED
Sprint Corporation
S
$293K ﹤0.01%
64,200
AROW icon
2189
Arrow Financial
AROW
$723M
$292K ﹤0.01%
13,973
NNBR icon
2190
NN Inc
NNBR
$298M
$291K ﹤0.01%
11,420
DNP icon
2191
DNP Select Income Fund
DNP
$4.11B
$289K ﹤0.01%
28,625
TTEC icon
2192
TTEC Holdings
TTEC
$77.4M
$289K ﹤0.01%
10,690
-90,400
-89% -$2.36M
UEIC icon
2193
Universal Electronics
UEIC
$66.6M
$289K ﹤0.01%
5,800
AUB icon
2194
Atlantic Union Bankshares
AUB
$6.09B
$288K ﹤0.01%
12,398
+2,000
+19% +$44.5K
GFF icon
2195
Griffon
GFF
$4.8B
$288K ﹤0.01%
18,100
TRST
2196
Trustco Bank Corp NY
TRST
$971M
$288K ﹤0.01%
8,190
BAC.PRL icon
2197
Bank of America Series L
BAC.PRL
$4.01B
$287K ﹤0.01%
254
RSTI
2198
DELISTED
Rofin-Sinar Technologies Inc
RSTI
$287K ﹤0.01%
10,400
UHT
2199
Universal Health Realty Income Trust
UHT
$573M
$286K ﹤0.01%
6,150
SC
2200
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$286K ﹤0.01%
11,200

Similar funds

T. Rowe Price Associates's Q2 2015 Portfolio in Review

As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
  • T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
  • T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
  • T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
  • T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
  • T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
  • T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.